First Time Loading...

CareDx Inc
NASDAQ:CDNA

Watchlist Manager
CareDx Inc Logo
CareDx Inc
NASDAQ:CDNA
Watchlist
Price: 8.31 USD 2.97% Market Closed
Updated: Apr 20, 2024

Intrinsic Value

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. [ Read More ]

The intrinsic value of one CDNA stock under the Base Case scenario is 12.81 USD. Compared to the current market price of 8.31 USD, CareDx Inc is Undervalued by 35%.

Key Points:
CDNA Intrinsic Value
Base Case
12.81 USD
Undervaluation 35%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
CareDx Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling CDNA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
CareDx Inc

Provide an overview of the primary business activities
of CareDx Inc.

What unique competitive advantages
does CareDx Inc hold over its rivals?

What risks and challenges
does CareDx Inc face in the near future?

Has there been any significant insider trading activity
in CareDx Inc recently?

Summarize the latest earnings call
of CareDx Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for CareDx Inc.

Provide P/S
for CareDx Inc.

Provide P/E
for CareDx Inc.

Provide P/OCF
for CareDx Inc.

Provide P/FCFE
for CareDx Inc.

Provide P/B
for CareDx Inc.

Provide EV/S
for CareDx Inc.

Provide EV/GP
for CareDx Inc.

Provide EV/EBITDA
for CareDx Inc.

Provide EV/EBIT
for CareDx Inc.

Provide EV/OCF
for CareDx Inc.

Provide EV/FCFF
for CareDx Inc.

Provide EV/IC
for CareDx Inc.

Show me price targets
for CareDx Inc made by professional analysts.

What are the Revenue projections
for CareDx Inc?

How accurate were the past Revenue estimates
for CareDx Inc?

What are the Net Income projections
for CareDx Inc?

How accurate were the past Net Income estimates
for CareDx Inc?

What are the EPS projections
for CareDx Inc?

How accurate were the past EPS estimates
for CareDx Inc?

What are the EBIT projections
for CareDx Inc?

How accurate were the past EBIT estimates
for CareDx Inc?

Compare the revenue forecasts
for CareDx Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of CareDx Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of CareDx Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of CareDx Inc compared to its peers.

Compare the P/E ratios
of CareDx Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing CareDx Inc with its peers.

Analyze the financial leverage
of CareDx Inc compared to its main competitors.

Show all profitability ratios
for CareDx Inc.

Provide ROE
for CareDx Inc.

Provide ROA
for CareDx Inc.

Provide ROIC
for CareDx Inc.

Provide ROCE
for CareDx Inc.

Provide Gross Margin
for CareDx Inc.

Provide Operating Margin
for CareDx Inc.

Provide Net Margin
for CareDx Inc.

Provide FCF Margin
for CareDx Inc.

Show all solvency ratios
for CareDx Inc.

Provide D/E Ratio
for CareDx Inc.

Provide D/A Ratio
for CareDx Inc.

Provide Interest Coverage Ratio
for CareDx Inc.

Provide Altman Z-Score Ratio
for CareDx Inc.

Provide Quick Ratio
for CareDx Inc.

Provide Current Ratio
for CareDx Inc.

Provide Cash Ratio
for CareDx Inc.

What is the historical Revenue growth
over the last 5 years for CareDx Inc?

What is the historical Net Income growth
over the last 5 years for CareDx Inc?

What is the current Free Cash Flow
of CareDx Inc?

Financials

Balance Sheet Decomposition
CareDx Inc

Current Assets 313.7m
Cash & Short-Term Investments 235.4m
Receivables 51.1m
Other Current Assets 27.2m
Non-Current Assets 153.1m
PP&E 65.1m
Intangibles 86m
Other Non-Current Assets 1.9m
Current Liabilities 78.1m
Accounts Payable 12.9m
Accrued Liabilities 35.4m
Other Current Liabilities 29.8m
Non-Current Liabilities 127.4m
Other Non-Current Liabilities 127.4m
Efficiency

Earnings Waterfall
CareDx Inc

Revenue
280.3m USD
Cost of Revenue
-102m USD
Gross Profit
178.3m USD
Operating Expenses
-282.4m USD
Operating Income
-104m USD
Other Expenses
-86.2m USD
Net Income
-190.3m USD

Free Cash Flow Analysis
CareDx Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

CDNA Profitability Score
Profitability Due Diligence

CareDx Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Negative 1-Year Revenue Growth
21/100
Profitability
Score

CareDx Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

CDNA Solvency Score
Solvency Due Diligence

CareDx Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
56/100
Solvency
Score

CareDx Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CDNA Price Targets Summary
CareDx Inc

Wall Street analysts forecast CDNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CDNA is 12.65 USD with a low forecast of 10.1 USD and a high forecast of 15.75 USD.

Lowest
Price Target
10.1 USD
22% Upside
Average
Price Target
12.65 USD
52% Upside
Highest
Price Target
15.75 USD
90% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

CDNA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

CDNA Price
CareDx Inc

1M 1M
-17%
6M 6M
+56%
1Y 1Y
-4%
3Y 3Y
-88%
5Y 5Y
-68%
10Y 10Y
-8%
Annual Price Range
8.31
52w Low
4.9
52w High
12.86
Price Metrics
Average Annual Return 27.26%
Standard Deviation of Annual Returns 142.61%
Max Drawdown -95%
Shares Statistics
Market Capitalization 428m USD
Shares Outstanding 53 388 830
Percentage of Shares Shorted 13.2%

CDNA Return Decomposition
Main factors of price return

What is price return decomposition?

CDNA News

Other Videos

Company Profile

CareDx Inc Logo
CareDx Inc

Country

United States of America

Industry

Biotechnology

Market Cap

428m USD

Dividend Yield

0%

Description

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. The company is headquartered in South San Francisco, California and currently employs 633 full-time employees. The company went IPO on 2014-07-17. The firm is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The firm offers testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. Its commercially available testing services consist of AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its suite of AlloSeq products include AlloSeq Tx, AlloSeq cfDNA, AlloSeq HCT, TruSight HLA, Olerup SSP and QTYPE. The company develops and provides diagnostic surveillance testing services for various transplant recipients.

Contact

CALIFORNIA
South San Francisco
1 Tower Place, 9Th Floor
+14152872300.0
https://www.caredx.com/

IPO

2014-07-17

Employees

633

Officers

CFO & Principal Accounting Officer
Mr. Abhishek Jain
Executive Director
Dr. Peter Maag Ph.D.
President of Patient & Testing Services
Mr. Alexander L. Johnson
Chief Operating Officer
Ms. Marica Grskovic Ph.D.
Chief Scientific Officer
Dr. Robert N. Woodward Ph.D.
Senior VP, Chief Information Officer & Chief Information Security Officer
Mr. GS Jha
Show More
Vice President of Investor Relations
Mr. Ian Cooney
General Counsel
Jeffrey A. Novack
Senior VP & Head of Human Resources
Ms. Stacey Follon
Chief of Patient & Digital Solutions
Mr. Kashif Rathore
Show Less

See Also

Discover More
What is the Intrinsic Value of one CDNA stock?

The intrinsic value of one CDNA stock under the Base Case scenario is 12.81 USD.

Is CDNA stock undervalued or overvalued?

Compared to the current market price of 8.31 USD, CareDx Inc is Undervalued by 35%.